Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning

Brain, Behavior, and Immunity

Volumn 22, Issue 4, 2008, Pages 538-543

  Jones, Richard E ^a,b   Moes, Nicole ^a,b   Zwickey, Heather ^c   Cunningham, Christopher L ^b   Gregory, William L ^c   Oken, Barry ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c National College of Natural Medicine   (United States)

Author keywords

Alpha lipoic acid; Animal model; Behavioral conditioning; EAE; Experimental autoimmune encephalomyelitis; Mouse; SJL; Therapy; Thioctic acid

Indexed keywords

DRINKING WATER; MYELIN; SACCHARIN; THIOCTIC ACID;

ACTIVE IMMUNIZATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STIMULUS; SWISS JAMES LAMBERT MOUSE; WATER DEPRIVATION;

ANIMALS; ANTIOXIDANTS; ASSOCIATION LEARNING; COMBINED MODALITY THERAPY; CONDITIONING (PSYCHOLOGY); DRINKING; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED STRAINS; SACCHARIN; SWEETENING AGENTS; THIOCTIC ACID; WATER DEPRIVATION;

EID: 41349084195     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.10.017     Document Type: Article

References (22)

1. Ader R. The role of conditioning in pharmacotherapy. In: Harrington A. (Ed). The Placebo Effect: An Interdisciplinary Exploration (1997), Harvard University Press, Cambridge, MA 138-165
2. Ader R. Conditioned immunomodulation: research needs and directions. Brain Behav. Immun. 17 Suppl. 1 (2003) S51-S57
3. Ader R., and Cohen N. Behaviorally conditioned immunosuppression. Psychosom. Med. 37 (1975) 333-340
4. Ader R., Cohen N., Ader R., Felten D.L., and Cohen N. Conditioning and Immunity. Psychoneuroimmunology vol. 3 (2001), Academic Press, New York pp. 3-34
5. Ader R., Kelly K., Moynihan J.A., Grota L.J., and Cohen N. Conditioned enhancement of antibody production using antigen as the unconditioned stimulus. Brain Behav. Immun. 7 (1993) 334-343
6. Benedetti F., Mayberg H.S., Wager T.D., Stohler C.S., and Zubieta J.K. Neurobiological mechanisms of the placebo effect. J. Neurosci. 25 (2005) 10390-10402
7. Exton M.S., Schult M., Donath S., Strubel T., Bode U., del Rey A., Westermann J., and Schedlowski M. Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am. J. Physiol. 276 (1999) R1710-R1717
8. Exton M.S., von Horsten S., Schult M., Voge J., Strubel T., Donath S., Steinmuller C., Seeliger H., Nagel E., Westermann J., and Schedlowski M. Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation. J. Neuroimmunol. 88 (1998) 182-191
9. Fleming K.K., Bovaird J.A., Mosier M.C., Emerson M.R., LeVine S.M., and Marquis J.G. Statistical analysis of data from studies on experimental autoimmune encephalomyelitis. J. Neuroimmunol. 170 (2005) 71-84 Epub 2005 Sep 2029
10. Ghanta V., Hiramoto R.N., Solvason B., and Spector N.H. Influence of conditioned natural immunity on tumor growth. Ann. N.Y. Acad. Sci. 496 (1987) 637-646
11. Gottlieb D.A. Acquisition with partial and continuous reinforcement in pigeon autoshaping. Learn Behav. 32 (2004) 321-334
12. Hucklebridge F. Behavioral conditioning of the immune system. Int. Rev. Neurobiol. 52 (2002) 325-351
13. Janz L.J., Green-Johnson J., Murray L., Vriend C.Y., Nance D.M., Greenberg A.H., and Dyck D.G. Pavlovian conditioning of LPS-induced responses: effects on corticosterone, splenic NE, and IL-2 production. Physiol. Behav. 59 (1996) 1103-1109
14. Jones R.E., Bourdette D., Moes N., Vandenbark A., Zamora A., and Offner H. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. J. Immunol. 170 (2003) 1690-1698
15. Klosterhalfen W., and Klosterhalfen S. Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats. Behav. Neurosci. 97 (1983) 663-666
16. Marracci G.H., Jones R.E., McKeon G.P., and Bourdette D.N. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J. Neuroimmunol. 131 (2002) 104-114
17. Morini M., Roccatagliata L., Dell'Eva R., Pedemonte E., Furlan R., Minghelli S., Giunti D., Pfeffer U., Marchese M., Noonan D., Mancardi G., Albini A., and Uccelli A. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148 (2004) 146-153
18. Niemi M.B., Pacheco-Lopez G., Kou W., Harting M., Rey A.D., Besedovsky H.O., and Schedlowski M. Murine taste-immune associative learning. Brain Behav. Immun. 20 (2006) 527-531
19. Pacheco-Lopez G., Engler H., Niemi M.B., and Schedlowski M. Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain Behav. Immun. 20 (2006) 430-446
20. Ramirez-Amaya V., and Bermudez-Rattoni F. Conditioned enhancement of antibody production is disrupted by insular cortex and amygdala but not hippocampal lesions. Brain Behav. Immun. 13 (1999) 46-60
21. Risinger F.O., and Cunningham C.L. Genetic differences in ethanol-induced hyperglycemia and conditioned taste aversion. Life Sci. 50 (1992) PL113-PL118
22. Sanna V., Di Giacomo A., La Cava A., Lechler R.I., Fontana S., Zappacosta S., and Matarese G. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111 (2003) 241-250